IRadimed specializes in MRI patient care, offering products such as MRI infusion pumps and MRI patient monitors. The company provides devices designed for use in the MRI environment.

iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.

COM:IRADIMED

IRadimed

Last Close

53.23

22/11 21:00

Market Cap

674.61M

Beta: -

Volume Today

41.99K

Avg: -

locale

market

industry

website

ipo date

peer of

Metrics